North America Genetic Testing Market (2019-2025)
The North America Genetic Testing Market would witness market growth of 10.6% CAGR during the forecast period (2019-2025).
The incidence of genetic disorders has grown dramatically, which can be caused by several factors, including geographical and environmental changes, significant changes in food habits, pollution, and exposure to risky radiations or chemicals. Genetic testing also serves to evaluate relationships between relatives, including mother, father, half-brother, half-sister, and other people. Forensics and genetic testing have greatly helped the law and order. The overall industry for genetic tests has been expanding and is anticipated to grow rapidly in the near future since more organizations are joining this market.
Diagnostic tests are used to detect or exclude a particular genetic or chromosomal condition. Often genetic testing is used to verify a diagnosis when physical signs and symptoms are suspected of a particular condition. Diagnostic tests may be performed before and at any moment of birth, but not for each gene or genetic condition. Diagnostic test findings can affect a person's health care and disorder management decisions.
Based on Type, the market is segmented into Predictive and Presymptomatic Carrier Testing, Prenatal and Newborn Testing, Diagnostic Testing, Pharmacogenomic Testing, and Other Types. Based on Technology, the market is segmented into Cytogenetic Testing, Biochemical Testing and Molecular Testing. Based on Application, the market is segmented into Cancer Diagnosis, Genetic Disease Diagnosis, Cardiovascular Disease Diagnosis and Other Applications. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Myriad Genetics, Inc., Empire Genomics LLC, Bio-Rad Laboratories, Inc., Novartis AG, Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., Qiagen N.V., Illumina, Inc., Danaher Corporation, and Abbott Laboratories (Abbott Laboratories Molecular, Inc.).
Scope of the Study
Market Segmentation:
By Type
The incidence of genetic disorders has grown dramatically, which can be caused by several factors, including geographical and environmental changes, significant changes in food habits, pollution, and exposure to risky radiations or chemicals. Genetic testing also serves to evaluate relationships between relatives, including mother, father, half-brother, half-sister, and other people. Forensics and genetic testing have greatly helped the law and order. The overall industry for genetic tests has been expanding and is anticipated to grow rapidly in the near future since more organizations are joining this market.
Diagnostic tests are used to detect or exclude a particular genetic or chromosomal condition. Often genetic testing is used to verify a diagnosis when physical signs and symptoms are suspected of a particular condition. Diagnostic tests may be performed before and at any moment of birth, but not for each gene or genetic condition. Diagnostic test findings can affect a person's health care and disorder management decisions.
Based on Type, the market is segmented into Predictive and Presymptomatic Carrier Testing, Prenatal and Newborn Testing, Diagnostic Testing, Pharmacogenomic Testing, and Other Types. Based on Technology, the market is segmented into Cytogenetic Testing, Biochemical Testing and Molecular Testing. Based on Application, the market is segmented into Cancer Diagnosis, Genetic Disease Diagnosis, Cardiovascular Disease Diagnosis and Other Applications. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Myriad Genetics, Inc., Empire Genomics LLC, Bio-Rad Laboratories, Inc., Novartis AG, Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., Qiagen N.V., Illumina, Inc., Danaher Corporation, and Abbott Laboratories (Abbott Laboratories Molecular, Inc.).
Scope of the Study
Market Segmentation:
By Type
- Predictive and Presymptomatic Carrier Testing
- Prenatal and Newborn Testing
- Diagnostic Testing
- Pharmacogenomic Testing
- Other Types
- Cytogenetic Testing
- Biochemical Testing and
- Molecular Testing
- Cancer Diagnosis
- Genetic Disease Diagnosis
- Cardiovascular Disease Diagnosis and
- Other Applications
- US
- Canada
- Mexico
- Rest of North America
- Myriad Genetics, Inc.
- Empire Genomics LLC
- Bio-Rad Laboratories, Inc.
- Novartis AG
- Agilent Technologies, Inc.
- Thermo Fisher Scientific, Inc.
- Qiagen N.V.
- Illumina, Inc.
- Danaher Corporation
- Abbott Laboratories (Abbott Laboratories Molecular, Inc.)
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
CHAPTER 1. MARKET SCOPE & METHODOLOGY
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Genetic Testing Market, by Type
1.4.2 North America Genetic Testing Market, by Technology
1.4.3 North America Genetic Testing Market, by Application
1.4.4 North America Genetic Testing Market, by Country
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.1.1 Overview
2.1.2 Executive Summary
2.1.3 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
CHAPTER 3. NORTH AMERICA GENETIC TESTING MARKET BY TYPE
3.1 North America Predictive and Presymptomatic Testing Market by Country
3.2 North America Carrier Testing Market by Country
3.3 North America Prenatal and Newborn Testing Market by Country
3.4 North America Diagnostic Testing Market by Country
3.5 North America Pharmacogenomic Testing Market by Country
3.6 North America Other Types Genetic Testing Market by Country
CHAPTER 4. NORTH AMERICA GENETIC TESTING MARKET BY TECHNOLOGY
4.1 North America Cytogenetic Testing Market by Country
4.2 North America Biochemical Testing Market by Country
4.3 North America Molecular Testing Market by Country
CHAPTER 5. NORTH AMERICA GENETIC TESTING MARKET BY APPLICATION
5.1 North America Cancer Diagnosis Market by Country
5.2 North America Genetic Disease Diagnosis Market by Country
5.3 North America Cardiovascular Disease Diagnosis Market by Country
5.4 North America Other Applications Market by Country
CHAPTER 6. NORTH AMERICA GENETIC TESTING MARKET BY COUNTRY
6.1 USA Genetic Testing Market
6.1.1 USA Genetic Testing Market by Type
6.1.2 USA Genetic Testing Market by Technology
6.1.3 USA Genetic Testing Market by Application
6.2 Canada Genetic Testing Market
6.2.1 Canada Genetic Testing Market by Type
6.2.2 Canada Genetic Testing Market by Technology
6.2.3 Canada Genetic Testing Market by Application
6.3 Mexico Genetic Testing Market
6.3.1 Mexico Genetic Testing Market by Type
6.3.2 Mexico Genetic Testing Market by Technology
6.3.3 Mexico Genetic Testing Market by Application
6.4 Rest of North America Genetic Testing Market
6.4.1 Rest of North America Genetic Testing Market by Type
6.4.2 Rest of North America Genetic Testing Market by Technology
6.4.3 Rest of North America Genetic Testing Market by Application
CHAPTER 7. COMPANY PROFILES
7.1 Myriad Genetics, Inc.
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental Analysis
7.1.4 Research & Development Expense
7.1.5 Recent strategies and developments:
7.1.5.1 Product Launches:
7.1.5.2 Collaborations, Partnerships and agreements:
7.2 Empire Genomics LLC
7.2.1 Company Overview
7.3 Bio-Rad laboratories, Inc.
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Recent strategies and developments:
7.3.4.1 Collaborations, partnerships and agreements:
7.3.4.2 Product launches:
7.3.4.3 Acquisition and mergers:
7.3.5 Research & Development Expenses
7.4 Novartis AG
7.4.1 Company Overview
7.4.1 Financial Analysis
7.4.2 Segmental and Regional Analysis
7.4.3 Research & Development Expense
7.4.4 Recent strategies and developments:
7.4.4.1 Collaborations, partnerships and agreements:
7.5 Agilent Technologies, Inc.
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.5.5 Recent strategies and developments:
7.5.5.1 Product launches:
7.5.5.2 Expansions:
7.6 Thermo Fischer Scientific, Inc.
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expense
7.6.5 Recent strategies and developments:
7.6.5.1 Collaborations, partnerships and agreements:
7.6.5.2 Acquisition and mergers:
7.7 Qiagen N.V.
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Regional Analysis
7.7.4 Research & Development Expense
7.7.5 Recent strategies and developments:
7.7.5.1 Product launches:
7.7.5.2 Collaborations, partnerships and agreements:
7.8 Illumina, Inc.
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Regional Analysis
7.8.4 Research & Development Expense
7.8.5 Recent strategies and developments:
7.8.5.1 Collaborations, partnerships and agreements:
7.8.5.2 Product launches:
7.9 Danaher Corporation
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental and Regional Analysis
7.9.4 Research & Development Expense
7.9.5 Recent strategies and developments:
7.9.5.1 Acquisition and mergers:
7.1 Abbott Laboratories (Abbott Laboratories Molecular, Inc.)
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Segmental and Regional Analysis
7.10.4 Research & Development Expense
7.10.5 Recent strategies and developments:
7.10.5.1 Collaborations, partnerships and agreements:
7.10.5.2 Product launches:
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Genetic Testing Market, by Type
1.4.2 North America Genetic Testing Market, by Technology
1.4.3 North America Genetic Testing Market, by Application
1.4.4 North America Genetic Testing Market, by Country
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.1.1 Overview
2.1.2 Executive Summary
2.1.3 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
CHAPTER 3. NORTH AMERICA GENETIC TESTING MARKET BY TYPE
3.1 North America Predictive and Presymptomatic Testing Market by Country
3.2 North America Carrier Testing Market by Country
3.3 North America Prenatal and Newborn Testing Market by Country
3.4 North America Diagnostic Testing Market by Country
3.5 North America Pharmacogenomic Testing Market by Country
3.6 North America Other Types Genetic Testing Market by Country
CHAPTER 4. NORTH AMERICA GENETIC TESTING MARKET BY TECHNOLOGY
4.1 North America Cytogenetic Testing Market by Country
4.2 North America Biochemical Testing Market by Country
4.3 North America Molecular Testing Market by Country
CHAPTER 5. NORTH AMERICA GENETIC TESTING MARKET BY APPLICATION
5.1 North America Cancer Diagnosis Market by Country
5.2 North America Genetic Disease Diagnosis Market by Country
5.3 North America Cardiovascular Disease Diagnosis Market by Country
5.4 North America Other Applications Market by Country
CHAPTER 6. NORTH AMERICA GENETIC TESTING MARKET BY COUNTRY
6.1 USA Genetic Testing Market
6.1.1 USA Genetic Testing Market by Type
6.1.2 USA Genetic Testing Market by Technology
6.1.3 USA Genetic Testing Market by Application
6.2 Canada Genetic Testing Market
6.2.1 Canada Genetic Testing Market by Type
6.2.2 Canada Genetic Testing Market by Technology
6.2.3 Canada Genetic Testing Market by Application
6.3 Mexico Genetic Testing Market
6.3.1 Mexico Genetic Testing Market by Type
6.3.2 Mexico Genetic Testing Market by Technology
6.3.3 Mexico Genetic Testing Market by Application
6.4 Rest of North America Genetic Testing Market
6.4.1 Rest of North America Genetic Testing Market by Type
6.4.2 Rest of North America Genetic Testing Market by Technology
6.4.3 Rest of North America Genetic Testing Market by Application
CHAPTER 7. COMPANY PROFILES
7.1 Myriad Genetics, Inc.
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental Analysis
7.1.4 Research & Development Expense
7.1.5 Recent strategies and developments:
7.1.5.1 Product Launches:
7.1.5.2 Collaborations, Partnerships and agreements:
7.2 Empire Genomics LLC
7.2.1 Company Overview
7.3 Bio-Rad laboratories, Inc.
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Recent strategies and developments:
7.3.4.1 Collaborations, partnerships and agreements:
7.3.4.2 Product launches:
7.3.4.3 Acquisition and mergers:
7.3.5 Research & Development Expenses
7.4 Novartis AG
7.4.1 Company Overview
7.4.1 Financial Analysis
7.4.2 Segmental and Regional Analysis
7.4.3 Research & Development Expense
7.4.4 Recent strategies and developments:
7.4.4.1 Collaborations, partnerships and agreements:
7.5 Agilent Technologies, Inc.
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.5.5 Recent strategies and developments:
7.5.5.1 Product launches:
7.5.5.2 Expansions:
7.6 Thermo Fischer Scientific, Inc.
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expense
7.6.5 Recent strategies and developments:
7.6.5.1 Collaborations, partnerships and agreements:
7.6.5.2 Acquisition and mergers:
7.7 Qiagen N.V.
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Regional Analysis
7.7.4 Research & Development Expense
7.7.5 Recent strategies and developments:
7.7.5.1 Product launches:
7.7.5.2 Collaborations, partnerships and agreements:
7.8 Illumina, Inc.
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Regional Analysis
7.8.4 Research & Development Expense
7.8.5 Recent strategies and developments:
7.8.5.1 Collaborations, partnerships and agreements:
7.8.5.2 Product launches:
7.9 Danaher Corporation
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental and Regional Analysis
7.9.4 Research & Development Expense
7.9.5 Recent strategies and developments:
7.9.5.1 Acquisition and mergers:
7.1 Abbott Laboratories (Abbott Laboratories Molecular, Inc.)
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Segmental and Regional Analysis
7.10.4 Research & Development Expense
7.10.5 Recent strategies and developments:
7.10.5.1 Collaborations, partnerships and agreements:
7.10.5.2 Product launches:
LIST OF TABLES
TABLE 1 NORTH AMERICA GENETIC TESTING MARKET, 2015 - 2018, USD MILLION
TABLE 2 NORTH AMERICA GENETIC TESTING MARKET, 2019 - 2025, USD MILLION
TABLE 3 NORTH AMERICA GENETIC TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 4 NORTH AMERICA GENETIC TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 5 NORTH AMERICA PREDICTIVE AND PRESYMPTOMATIC TESTING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 6 NORTH AMERICA PREDICTIVE AND PRESYMPTOMATIC TESTING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 7 NORTH AMERICA CARRIER TESTING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 8 NORTH AMERICA CARRIER TESTING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 9 NORTH AMERICA PRENATAL AND NEWBORN TESTING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 10 NORTH AMERICA PRENATAL AND NEWBORN TESTING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 11 NORTH AMERICA DIAGNOSTIC TESTING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 12 NORTH AMERICA DIAGNOSTIC TESTING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 13 NORTH AMERICA PHARMACOGENOMIC TESTING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 14 NORTH AMERICA PHARMACOGENOMIC TESTING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 15 NORTH AMERICA OTHER TYPES GENETIC TESTING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 16 NORTH AMERICA OTHER TYPES GENETIC TESTING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 17 NORTH AMERICA GENETIC TESTING MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 18 NORTH AMERICA GENETIC TESTING MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 19 NORTH AMERICA CYTOGENETIC TESTING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 20 NORTH AMERICA CYTOGENETIC TESTING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 21 NORTH AMERICA BIOCHEMICAL TESTING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 22 NORTH AMERICA BIOCHEMICAL TESTING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 23 NORTH AMERICA MOLECULAR TESTING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 24 NORTH AMERICA MOLECULAR TESTING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 25 NORTH AMERICA GENETIC TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 26 NORTH AMERICA GENETIC TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 27 NORTH AMERICA CANCER DIAGNOSIS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 28 NORTH AMERICA CANCER DIAGNOSIS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 29 NORTH AMERICA GENETIC DISEASE DIAGNOSIS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 30 NORTH AMERICA GENETIC DISEASE DIAGNOSIS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 31 NORTH AMERICA CARDIOVASCULAR DISEASE DIAGNOSIS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 32 NORTH AMERICA CARDIOVASCULAR DISEASE DIAGNOSIS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 33 NORTH AMERICA OTHER APPLICATIONS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 34 NORTH AMERICA OTHER APPLICATIONS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 35 NORTH AMERICA GENETIC TESTING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 36 NORTH AMERICA GENETIC TESTING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 37 USA GENETIC TESTING MARKET, 2015 - 2018, USD MILLION
TABLE 38 USA GENETIC TESTING MARKET, 2019 - 2025, USD MILLION
TABLE 39 USA GENETIC TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 40 USA GENETIC TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 41 USA GENETIC TESTING MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 42 USA GENETIC TESTING MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 43 USA GENETIC TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 44 USA GENETIC TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 45 CANADA GENETIC TESTING MARKET, 2015 - 2018, USD MILLION
TABLE 46 CANADA GENETIC TESTING MARKET, 2019 - 2025, USD MILLION
TABLE 47 CANADA GENETIC TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 48 CANADA GENETIC TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 49 CANADA GENETIC TESTING MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 50 CANADA GENETIC TESTING MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 51 CANADA GENETIC TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 52 CANADA GENETIC TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 53 MEXICO GENETIC TESTING MARKET, 2015 - 2018, USD MILLION
TABLE 54 MEXICO GENETIC TESTING MARKET, 2019 - 2025, USD MILLION
TABLE 55 MEXICO GENETIC TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 56 MEXICO GENETIC TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 57 MEXICO GENETIC TESTING MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 58 MEXICO GENETIC TESTING MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 59 MEXICO GENETIC TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 60 MEXICO GENETIC TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 61 REST OF NORTH AMERICA GENETIC TESTING MARKET, 2015 - 2018, USD MILLION
TABLE 62 REST OF NORTH AMERICA GENETIC TESTING MARKET, 2019 - 2025, USD MILLION
TABLE 63 REST OF NORTH AMERICA GENETIC TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 64 REST OF NORTH AMERICA GENETIC TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 65 REST OF NORTH AMERICA GENETIC TESTING MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 66 REST OF NORTH AMERICA GENETIC TESTING MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 67 REST OF NORTH AMERICA GENETIC TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 68 REST OF NORTH AMERICA GENETIC TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 69 KEY INFORMATION – MYRIAD GENETICS, INC.
TABLE 70 KEY INFORMATION – EMPIRE GENOMICS LLC
TABLE 71 KEY INFORMATION – BIO-RAD LABORATORIES, INC.
TABLE 72 KEY INFORMATION – NOVARTIS AG
TABLE 73 KEY INFORMATION – AGILENT TECHNOLOGIES, INC.
TABLE 74 KEY INFORMATION – THERMO FISHER SCIENTIFIC, INC.
TABLE 75 KEY INFORMATION – QIAGEN N.V.
TABLE 76 KEY INFORMATION – ILLUMINA, INC.
TABLE 77 KEY INFORMATION – DANAHER CORPORATION
TABLE 78 KEY INFORMATION – ABBOTT LABORATORIES
TABLE 1 NORTH AMERICA GENETIC TESTING MARKET, 2015 - 2018, USD MILLION
TABLE 2 NORTH AMERICA GENETIC TESTING MARKET, 2019 - 2025, USD MILLION
TABLE 3 NORTH AMERICA GENETIC TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 4 NORTH AMERICA GENETIC TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 5 NORTH AMERICA PREDICTIVE AND PRESYMPTOMATIC TESTING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 6 NORTH AMERICA PREDICTIVE AND PRESYMPTOMATIC TESTING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 7 NORTH AMERICA CARRIER TESTING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 8 NORTH AMERICA CARRIER TESTING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 9 NORTH AMERICA PRENATAL AND NEWBORN TESTING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 10 NORTH AMERICA PRENATAL AND NEWBORN TESTING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 11 NORTH AMERICA DIAGNOSTIC TESTING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 12 NORTH AMERICA DIAGNOSTIC TESTING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 13 NORTH AMERICA PHARMACOGENOMIC TESTING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 14 NORTH AMERICA PHARMACOGENOMIC TESTING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 15 NORTH AMERICA OTHER TYPES GENETIC TESTING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 16 NORTH AMERICA OTHER TYPES GENETIC TESTING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 17 NORTH AMERICA GENETIC TESTING MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 18 NORTH AMERICA GENETIC TESTING MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 19 NORTH AMERICA CYTOGENETIC TESTING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 20 NORTH AMERICA CYTOGENETIC TESTING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 21 NORTH AMERICA BIOCHEMICAL TESTING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 22 NORTH AMERICA BIOCHEMICAL TESTING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 23 NORTH AMERICA MOLECULAR TESTING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 24 NORTH AMERICA MOLECULAR TESTING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 25 NORTH AMERICA GENETIC TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 26 NORTH AMERICA GENETIC TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 27 NORTH AMERICA CANCER DIAGNOSIS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 28 NORTH AMERICA CANCER DIAGNOSIS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 29 NORTH AMERICA GENETIC DISEASE DIAGNOSIS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 30 NORTH AMERICA GENETIC DISEASE DIAGNOSIS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 31 NORTH AMERICA CARDIOVASCULAR DISEASE DIAGNOSIS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 32 NORTH AMERICA CARDIOVASCULAR DISEASE DIAGNOSIS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 33 NORTH AMERICA OTHER APPLICATIONS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 34 NORTH AMERICA OTHER APPLICATIONS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 35 NORTH AMERICA GENETIC TESTING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 36 NORTH AMERICA GENETIC TESTING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 37 USA GENETIC TESTING MARKET, 2015 - 2018, USD MILLION
TABLE 38 USA GENETIC TESTING MARKET, 2019 - 2025, USD MILLION
TABLE 39 USA GENETIC TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 40 USA GENETIC TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 41 USA GENETIC TESTING MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 42 USA GENETIC TESTING MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 43 USA GENETIC TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 44 USA GENETIC TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 45 CANADA GENETIC TESTING MARKET, 2015 - 2018, USD MILLION
TABLE 46 CANADA GENETIC TESTING MARKET, 2019 - 2025, USD MILLION
TABLE 47 CANADA GENETIC TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 48 CANADA GENETIC TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 49 CANADA GENETIC TESTING MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 50 CANADA GENETIC TESTING MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 51 CANADA GENETIC TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 52 CANADA GENETIC TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 53 MEXICO GENETIC TESTING MARKET, 2015 - 2018, USD MILLION
TABLE 54 MEXICO GENETIC TESTING MARKET, 2019 - 2025, USD MILLION
TABLE 55 MEXICO GENETIC TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 56 MEXICO GENETIC TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 57 MEXICO GENETIC TESTING MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 58 MEXICO GENETIC TESTING MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 59 MEXICO GENETIC TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 60 MEXICO GENETIC TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 61 REST OF NORTH AMERICA GENETIC TESTING MARKET, 2015 - 2018, USD MILLION
TABLE 62 REST OF NORTH AMERICA GENETIC TESTING MARKET, 2019 - 2025, USD MILLION
TABLE 63 REST OF NORTH AMERICA GENETIC TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 64 REST OF NORTH AMERICA GENETIC TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 65 REST OF NORTH AMERICA GENETIC TESTING MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 66 REST OF NORTH AMERICA GENETIC TESTING MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 67 REST OF NORTH AMERICA GENETIC TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 68 REST OF NORTH AMERICA GENETIC TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 69 KEY INFORMATION – MYRIAD GENETICS, INC.
TABLE 70 KEY INFORMATION – EMPIRE GENOMICS LLC
TABLE 71 KEY INFORMATION – BIO-RAD LABORATORIES, INC.
TABLE 72 KEY INFORMATION – NOVARTIS AG
TABLE 73 KEY INFORMATION – AGILENT TECHNOLOGIES, INC.
TABLE 74 KEY INFORMATION – THERMO FISHER SCIENTIFIC, INC.
TABLE 75 KEY INFORMATION – QIAGEN N.V.
TABLE 76 KEY INFORMATION – ILLUMINA, INC.
TABLE 77 KEY INFORMATION – DANAHER CORPORATION
TABLE 78 KEY INFORMATION – ABBOTT LABORATORIES
LIST OF FIGURES
FIG 1 METHODOLOGY FOR THE RESEARCH
FIG 1 METHODOLOGY FOR THE RESEARCH
